Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

Ibandronate Sodium Catalog No.:M8787-2 3 μM BDP5290 completely inhibits

SKU: 39512010510

4.7
USD119.00 USD157.00

Pay in 4 interest-free payments of $29.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Live Spec

Ibandronate Sodium Catalog No.:M8787-2 3 μM BDP5290 completely inhibitsIbandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved

Store: schmucketriebe.at · Domain: schmucketriebe.at

Description

3 μM BDP5290 completely inhibits myosin II light chain (MLC) phosphorylation induced by MRCKβ

7(8):1447-52

000-fold selective for 20 other human methyltransferases

2005 Sep 30

Ibandronate Sodium Catalog No.:M8787-2 3 μM BDP5290 completely inhibitsIbandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products